Key Points
- Director Craig Barratt sold 750 shares of Intuitive Surgical on November 12 at an average price of $580, totaling $435,000, a transaction disclosed in an SEC filing.
- Intuitive Surgical reported a strong quarter with Q3 EPS of $2.40 vs. $1.99 expected and revenue of $2.51 billion (up 22.9% year-over-year), with a 28.6% net margin and 15.1% ROE.
- Analysts hold a consensus "Moderate Buy" on ISRG with a mean price target of $608.92, while the stock trades at a market cap of about $199.4B and a P/E of 73.7.
Intuitive Surgical, Inc. (NASDAQ:ISRG - Get Free Report) Director Craig Barratt sold 750 shares of the stock in a transaction on Wednesday, November 12th. The shares were sold at an average price of $580.00, for a total value of $435,000.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.
Intuitive Surgical Price Performance
ISRG stock traded down $9.26 during mid-day trading on Friday, hitting $556.26. 357,722 shares of the stock were exchanged, compared to its average volume of 2,115,559. The business has a fifty day moving average price of $480.86 and a 200 day moving average price of $502.93. Intuitive Surgical, Inc. has a 12 month low of $425.00 and a 12 month high of $616.00. The stock has a market capitalization of $199.40 billion, a price-to-earnings ratio of 73.73, a PEG ratio of 4.94 and a beta of 1.62.
Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share for the quarter, topping analysts' consensus estimates of $1.99 by $0.41. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The company had revenue of $2.51 billion during the quarter, compared to the consensus estimate of $2.41 billion. During the same quarter in the previous year, the company posted $1.84 EPS. Intuitive Surgical's quarterly revenue was up 22.9% compared to the same quarter last year. As a group, equities analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.
Analysts Set New Price Targets
A number of equities research analysts have recently issued reports on ISRG shares. Sanford C. Bernstein reaffirmed an "outperform" rating and issued a $685.00 price objective on shares of Intuitive Surgical in a research note on Tuesday, October 21st. Evercore ISI lifted their price target on Intuitive Surgical from $450.00 to $540.00 in a research note on Wednesday, October 22nd. Deutsche Bank Aktiengesellschaft restated a "sell" rating on shares of Intuitive Surgical in a report on Friday, August 22nd. Mizuho set a $575.00 price target on shares of Intuitive Surgical in a research report on Wednesday, October 22nd. Finally, Wall Street Zen lowered shares of Intuitive Surgical from a "buy" rating to a "hold" rating in a report on Saturday, November 8th. Two equities research analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, Intuitive Surgical has a consensus rating of "Moderate Buy" and a consensus price target of $608.92.
Read Our Latest Report on Intuitive Surgical
Institutional Inflows and Outflows
Several hedge funds and other institutional investors have recently made changes to their positions in the company. Tobam boosted its stake in Intuitive Surgical by 666.7% during the 2nd quarter. Tobam now owns 46 shares of the medical equipment provider's stock valued at $25,000 after purchasing an additional 40 shares during the last quarter. Kilter Group LLC purchased a new position in shares of Intuitive Surgical in the second quarter valued at about $27,000. Princeton Global Asset Management LLC bought a new position in shares of Intuitive Surgical in the second quarter worth about $30,000. TD Capital Management LLC grew its position in shares of Intuitive Surgical by 300.0% during the first quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider's stock worth $30,000 after purchasing an additional 45 shares in the last quarter. Finally, Greykasell Wealth Strategies Inc. bought a new stake in Intuitive Surgical during the 3rd quarter valued at approximately $27,000. Institutional investors own 83.64% of the company's stock.
Intuitive Surgical Company Profile
(
Get Free Report)
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
